Harvard Business Review on sexual harassment in health care

From HBR,  which has a three story pay-wall: Many factors make an organization prone to sexual harassment: a hierarchicalstructure, a male-dominated environment, and a climate that tolerates transgressions — particularly when they are committed by those with power. Medicinehas all three of these elements. And academic medicine, compared to other scientific fields, has the highest incidence of gender and … Continue reading Harvard Business Review on sexual harassment in health care

11/7 Live streamed Harvard event: “Addressing Adolescent Mental Health Beyond the Clinic: Lessons from the Global South”

Live streamed Harvard event on adolescent mental health beyond the clinic.  The Child Mental Health Forum talks run through May. 10 AM- 11:15 a.m.  at the Judge Baker Children’s Center 53 Parker Hill Avenue, Boston, Limited free parking available November 7th, 2018 “Addressing Adolescent Mental Health Beyond the Clinic: Lessons from the Global South” Vikram Patel, … Continue reading 11/7 Live streamed Harvard event: “Addressing Adolescent Mental Health Beyond the Clinic: Lessons from the Global South”

STAT: :Neuroinflammation is where we’re going to find [Alzheimer’s] drugs.”

That's what Rudolph Tanzi, a prominent Alzheimer's researcher at MGH says about the work of Robert Moir, a member of his team.  A story in STAT last week -- which ran in today's Globe - chronicles Moir's struggle to get funding for a theory that Alzheimer’s disease is a triggered by microbes in the brain. "If true, the … Continue reading STAT: :Neuroinflammation is where we’re going to find [Alzheimer’s] drugs.”

KHN: Drugmakers Funnel Millions To Lawmakers; A Few Dozen Get $100,000-Plus

defaultEmmarie Huetteman and Sydney Lupkin, Kaiser Health News Before the midterm elections heated up, dozens of drugmakers had already poured about $12 million into the war chests of hundreds of members of Congress. Since the beginning of last year, 34 lawmakers have each received more than $100,000 from pharmaceutical companies. Two of those — Reps. … Continue reading KHN: Drugmakers Funnel Millions To Lawmakers; A Few Dozen Get $100,000-Plus

Is the US setting the bar too low for new CF drug? Canada says it’s not worth it

From The Globe and Mail: Canadian governments should not pay for a $250,000-a-year cystic fibrosis medication because it is not clear the drug actually improves patients’ health, according to a fresh review that has devastated some with the potentially fatal lung disease.... In a report released on Thursday, the CADTH’s expert panel said its review … Continue reading Is the US setting the bar too low for new CF drug? Canada says it’s not worth it

Harvard study find that #immigrants’ #health #premiums exceed cost of care; Kaiser Health News explains

Carmen Heredia Rodriguez, Kaiser Health News President Donald Trump has repeatedly condemned U.S. immigration policy, arguing that many immigrants pose a threat to the nation and drain U.S. resources. But a study released Monday about health insurance challenges the president’s portrayal. The study in the journal Health Affairs found that immigrants covered by private health … Continue reading Harvard study find that #immigrants’ #health #premiums exceed cost of care; Kaiser Health News explains

Wednesday offers a burst of health #events in #Boston covering outbreaks, drug costs, AI and more

Wednesday 9/26 seems to be an extraordinary day for health and medicine events. Thanks to the calendar listing on   "Selected Lectures on Science and Engineering in the Boston Area" 10-1p.  "Media in the Age of Contagions."   A symposium.   HLS:  Wasserstein Hall, Milstein West (2019), 1585 Massachusetts Ave.   Details, Abstract, Registration. Noon.  "U.S. Drug Prices: Why Are … Continue reading Wednesday offers a burst of health #events in #Boston covering outbreaks, drug costs, AI and more